{
  "id": 5193,
  "text": "J Natl Cancer Inst 2010;102:315-324.Available at: http://www.ncbi.nlm.nih.gov/pubmed/20157096.12.Villa LL, Costa RL, Petta CA, et al.Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: J Natl Cancer Inst 2010;102:315-324.Available at: http://www.ncbi.nlm.nih.gov/pubmed/20157096.12.Villa LL, Costa RL, Petta CA, et al.Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial.\n\n<question>: ",
  "ChatGPT_response_0": "关于女性癌症预防疫苗的研究显示，预防性四价人乳头瘤病毒 (类型 6、11、16 和 18) L1 病毒样颗粒疫苗在年轻女性中的随机双盲安慰剂对照多中心二期疗效试验中取得了成功。这种疫苗已经被证实可以有效预防特定类型的人乳头瘤病毒感染，进而预防宫颈癌和其他相关疾病的发生。值得注意的是，这种疫苗在预防女性癌症方面取得了积极的成果，但除此之外的其他尝试或研究仍在不断进行，以进一步完善预防女性癌症的策略和方法。",
  "query": "有没有关于女性癌症预防疫苗的其他尝试或研究？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 有没有关于女性癌症预防疫苗的其他尝试或研究？\n\n<reference text>: J Natl Cancer Inst 2010;102:315-324.Available at: http://www.ncbi.nlm.nih.gov/pubmed/20157096.12.Villa LL, Costa RL, Petta CA, et al.Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial.\n\n<reply>: ",
  "response": "关于女性癌症预防疫苗的研究显示，预防性四价人乳头瘤病毒 (类型 6、11、16 和 18) L1 病毒样颗粒疫苗在年轻女性中的随机双盲安慰剂对照多中心二期疗效试验中取得了成功。这种疫苗已经被证实可以有效预防特定类型的人乳头瘤病毒感染，进而预防宫颈癌和其他相关疾病的发生。值得注意的是，这种疫苗在预防女性癌症方面取得了积极的成果，但除此之外的其他尝试或研究仍在不断进行，以进一步完善预防女性癌症的策略和方法。"
}